Skip to content
Entourage

Is your product a medical device or an IVD, and which class does it fall into?

We handle qualification and classification under the MDR and IVDR: medical device, IVD, medicinal product or cosmetic, and which class Annex VIII produces. Both follow from the intended purpose that the manufacturer defines and justifies in the technical documentation.

Overview

What decides whether the class holds?

Qualification and classification for medical devices and IVD · MDR Art. 1, 2, 4, 51 and Annex VIII · IVDR Art. 1, 2, 3, 47 and Annex VIII · MDCG 2021-24, 2020-16, 2019-11

Last updated: October 30, 2026

The manufacturer determines the status and class of a product. It justifies both in the technical documentation (Annex II Section 1.1(e) and (f) of the MDR and IVDR), and the notified body verifies them before issuing a quotation and when the application arrives (Annex VII Sections 4.2 and 4.3).

  • The intended purpose carries the class, not the product. Annex VIII is applied according to the intended purpose (MDR Section 3.1, IVDR Section 1.1), and under MDCG 2021-24 Rev. 1 it is the intended purpose assigned by the manufacturer that counts, not the class assigned to similar products. Two sutures of the same composition can therefore fall into different classes.
  • Where several rules apply, the strictest one governs. That is set out in MDR Annex VIII Section 3.5 and IVDR Annex VIII Section 1.9; where an IVD manufacturer states several intended purposes that lead to different classes, the higher class applies (IVDR Section 1.8).
  • At the border with medicinal products, the principal mode of action decides (Art. 1(6)(b) MDR). Under MDCG 2022-5 Rev. 1 it has to reflect state of the art scientific data; the manufacturer's claims alone do not move a product into the other category. If a product, taking into account all its characteristics, may fall under both definitions, medicinal product law applies (Art. 2(2) Directive 2001/83/EC).
  • Software has no class of its own while it drives a device or influences its use; it then takes the class of the device. Standalone software is classified in its own right (MDR Annex VIII Section 3.3, IVDR Section 1.4), under the MDR usually through Rule 11.

Industries

What this means in your industry

Select an industry

Medical Devices

What applies
MDR Art. 51 and Annex VIII with 22 rules and classes I, IIa, IIb and III; qualification under Art. 1 and 2, in individual cases by Commission implementing act under Art. 4.
Who audits
The notified body verifies qualification and class in the pre-application and application review (Annex VII Sections 4.2 and 4.3); in a dispute, the competent authority where the manufacturer has its registered place of business decides (Art. 51(2) MDR).

IVD

What applies
IVDR Art. 47 and Annex VIII with seven rules and classes A to D; qualification under Art. 1 and 2, in individual cases by implementing act under Art. 3.
Who audits
The notified body verifies qualification and class as under the MDR (Annex VII Sections 4.2 and 4.3 of the IVDR); disputes are decided by the competent authority where the manufacturer has its registered place of business (Art. 47(2) IVDR).

Services

How we support you

Product qualification

Assessment of whether the product meets the definition of a medical device (Art. 2(1) MDR), an IVD (Art. 2(2) IVDR), an accessory or an Annex XVI product, or falls under an exclusion in Art. 1(6) MDR such as medicinal products, cosmetics or food, and for laboratory products under Art. 1(3) IVDR. Deliverable: a qualification with references, as Annex II Section 1.1(e) requires.

Classification under Annex VIII

A walk through the implementing rules and every rule the intended purpose touches: 22 rules of the MDR with classes I, IIa, IIb and III, seven rules of the IVDR with classes A to D. Deliverable: the class with the justification for each rule applied, as Annex II Section 1.1(f) requires, and the rules that were checked and discarded.

Borderline cases and combinations

Devices incorporating a substance that would be a medicinal product if used separately (Art. 1(8) MDR, Rule 14), devices intended to administer medicinal products (Art. 1(9) MDR), substance-based devices (Rule 21), devices incorporating an IVD (Art. 1(7) MDR, Art. 1(4) IVDR) and accessories classified in their own right. Checked against the Manual on borderline and classification and MDCG 2022-5 Rev. 1.

What it comes down to

Whether a product is a medical device is decided by the definition in Art. 2(1) MDR: a medical purpose defined by the manufacturer, and a principal intended action that is not achieved by pharmacological, immunological or metabolic means. An IVD is a medical device that examines specimens derived from the human body in vitro and has one of the purposes listed in Art. 2(2) IVDR.

Art. 1(6) MDR draws the outer boundaries. Medicinal products, advanced therapy medicinal products, cosmetic products under Regulation (EC) No 1223/2009 and food are outside the MDR. For devices incorporating a medicinal substance or intended to administer medicinal products, Art. 1(8) and (9) set out which rules apply. If a product, taking into account all its characteristics, may be both a medicinal product and another product, medicinal product law takes precedence (Art. 2(2) Directive 2001/83/EC).

MDRIVDR
ClassesI, IIa, IIb, III (Art. 51)A, B, C, D (Art. 47)
Rules in Annex VIII22, with implementing rules in Chapter II7, with implementing rules in Section 1
Several rules applystrictest rule and sub-rule (Section 3.5)rule resulting in the higher class (Section 1.9)
Softwareclass of the device it drives, or standalone, Rule 11 (Section 3.3)class of the device it drives, or standalone (Section 1.4)
Dispute with the notified bodycompetent authority where the manufacturer is registered (Art. 51(2))competent authority where the manufacturer is registered (Art. 47(2))
MDCG guidanceMDCG 2021-24 Rev. 1, April 2026MDCG 2020-16 Rev. 5, September 2026

The class drives the conformity assessment route and thereby whether, and to what extent, a notified body is involved. That is why the MDR and IVDR require qualification and class to be justified in the technical documentation, and why the notified body checks both before it issues a quotation.

For borderline cases there are two sources outside the regulations: the MDCG guidance and the Manual on borderline and classification, in which the competent authorities record individual cases. Neither is binding. A classification only becomes binding through a Commission implementing act (Art. 4 and 51(3) MDR, Art. 3 and 47(3) IVDR) or a decision of the competent authority.

Outside the scope of this page are the route from the class to CE marking with the choice of conformity assessment procedure, the development of software to IEC 62304, IVDR implementation for a whole portfolio, and the choice of pathway at the FDA.

Our approach

Our approach

01

Define the intended purpose

An intended purpose that sets user, patient population, place of use and duration precisely enough to derive qualification and class from it.

02

Qualify

A reasoned qualification as medical device, IVD, accessory, Annex XVI product or product outside the MDR and IVDR, with the boundaries checked.

03

Classify

The class under Annex VIII with every rule applied and the implementing rules that determine it.

04

Align

A justification in the technical documentation that the notified body can follow in its application review, and open borderline questions with their reference in the Manual or the MDCG guidance.

Common pitfalls

Where projects commonly fail

The class from the time of Directive 93/42/EEC is carried over.

Its Annex IX had 18 rules, Annex VIII of the MDR has 22; Rules 19 to 22 are new (nanomaterials, inhalation of medicinal products, substance-based devices, active therapeutic devices with a diagnostic function), and Rule 11 now covers software, whereas in the Directive it governed active devices for administering substances (now Rule 12).

An accessory is given the class of the device it is used with.

The MDR and IVDR require accessories to be classified in their own right (MDR Annex VIII Section 3.2, IVDR Section 1.3). Under the IVDR, calibrators and control materials with assigned values are the exception: they take the class of the device (Sections 1.5 and 1.6).

A laboratory product is labeled Research Use Only and offered for diagnostic purposes at the same time.

The IVDR does not apply to research use only products unless the manufacturer specifically intends them for in vitro diagnostic examination (Art. 1(3)(a) IVDR); under MDCG 2024-11 such a product cannot have a medical purpose.

The intended purpose in the instructions for use is broader than the one the classification rests on.

Every intended purpose the manufacturer states counts for the class; with several, the higher class applies (IVDR Annex VIII Section 1.8, MDR Section 3.5).

Product Development & Regulatory Strategy

Do any of these pitfalls apply to you?

In a first call we assess your situation and say what needs clarifying first in your case. Without obligation, reply usually within one working day.

FAQ

Frequently asked questions

The manufacturer, with a justification for each rule applied in the technical documentation (Annex II Section 1.1(f) of the MDR and IVDR). The notified body verifies the classification before issuing a quotation and during the application review. A dispute is decided by the competent authority where the manufacturer has its registered place of business (Art. 51(2) MDR, Art. 47(2) IVDR), and for individual devices or groups of devices the Commission can determine the application of Annex VIII by implementing act.

Sources
  • Regulation (EU) 2017/745 (MDR), consolidated version CELEX 02017R0745-20260719: Art. 1, 2, 4, 51, Annex II Section 1.1, Annex VII Sections 4.2 and 4.3, Annex VIII, Annex XVI
  • Regulation (EU) 2017/746 (IVDR), consolidated version CELEX 02017R0746-20250110: Art. 1, 2, 3, 47, Annex II Section 1.1, Annex VII Sections 4.2 and 4.3, Annex VIII
  • Directive 2001/83/EC, consolidated version CELEX 02001L0083-20250101: Art. 2(2)
  • Regulation (EC) No 1223/2009 on cosmetic products: Art. 2(1)(a)
  • Directive 93/42/EEC concerning medical devices, consolidated version CELEX 01993L0042-20071011: Annex IX (classification criteria)
  • MDCG 2021-24 Rev. 1, Guidance on classification of medical devices (April 2026): https://health.ec.europa.eu/document/download/cbb19821-a517-4e13-bf87-fdc6ddd1782e_en?filename=mdcg_2021-24_en.pdf
  • MDCG 2020-16 Rev. 5, Guidance on Classification Rules for in vitro Diagnostic Medical Devices under Regulation (EU) 2017/746 (September 2026): https://health.ec.europa.eu/document/download/12f9756a-1e0d-4aed-9783-d948553f1705_en?filename=md_mdcg_2020_guidance_classification_ivd-md_en.pdf
  • MDCG 2019-11 Rev. 1, Guidance on Qualification and Classification of Software in Regulation (EU) 2017/745 and Regulation (EU) 2017/746 (June 2025): https://health.ec.europa.eu/document/download/b45335c5-1679-4c71-a91c-fc7a4d37f12b_en?filename=mdcg_2019_11_en.pdf
  • MDCG 2022-5 Rev. 1, Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745 (October 2024): https://health.ec.europa.eu/document/download/b5a27717-229f-4d7a-97b1-e1c7d819e579_en?filename=mdcg_2022-5_en.pdf
  • MDCG 2024-11, Guidance on qualification of in vitro diagnostic medical devices (October 2024): https://health.ec.europa.eu/document/download/12b92152-371f-404d-a865-93800cd5cdca_en?filename=mdcg_2024-11_en.pdf
  • Manual on borderline and classification for medical devices under Regulation (EU) 2017/745 and Regulation (EU) 2017/746, Version 5 (April 2026): https://health.ec.europa.eu/document/download/71a87df8-5ca1-4555-b453-b65bdf8de909_en?filename=md_borderline_manual_en.pdf
  • Helsinki Procedure 2021, Exchange of information between medical device competent authorities on borderline and classification cases (version of June 23, 2021)
  • 21 U.S.C. 360c(g) (FD&C Act Sec. 513(g)) and FDA Product Classification Database: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPCD/classification.cfm

Image notice: The images on this page were generated using artificial intelligence. They do not depict real people, places, or events.

Regulations & standards considered

  • EU 2017/745 (MDR), Art. 1(6) to (9) (exclusions and combinations with medicinal products)
  • EU 2017/745 (MDR), Art. 2(1) and (2) (medical device, accessory)
  • EU 2017/745 (MDR), Art. 4 (regulatory status of products)
  • EU 2017/745 (MDR), Art. 51 (classification of devices) and Annex VIII (classification rules 1 to 22)
  • EU 2017/745 (MDR), Annex II Section 1.1(e) and (f) (rationale for qualification and class in the technical documentation)
  • EU 2017/746 (IVDR), Art. 1(3) and (4), Art. 2(2), Art. 3, Art. 47 and Annex VIII (classification rules 1 to 7)
  • Directive 2001/83/EC, Art. 2(2) (cases of doubt between a medicinal product and another product)
  • Regulation (EC) No 1223/2009, Art. 2(1)(a) (cosmetic product)
  • MDCG 2021-24 Rev. 1 (classification of medical devices, April 2026)
  • MDCG 2020-16 Rev. 5 (classification rules for IVD, September 2026)
  • MDCG 2019-11 Rev. 1 (qualification and classification of software, June 2025)
  • MDCG 2022-5 Rev. 1 (borderline between medical devices and medicinal products, October 2024)

Have a concrete project?

Briefly outline your situation. We'll respond with an initial assessment, usually within one business day.

Prefer direct? info@theentourage.us

  • Reply usually within one working day
  • 4 locations: DE · CH · IT · US
  • 100% life sciences